Screener
Revolution Medicines, Inc. RVMD PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Revolution Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-208969
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Marketable securities | 1,467,145 | 1,641,934 |
| Prepaid expenses and other current assets | 59,829 | 49,358 |
| Total current assets | 1,967,913 | 2,075,037 |
| Property and equipment, net | 31,475 | 33,194 |
| Operating lease right-of-use asset | 129,895 | 132,084 |
| Intangible assets, net | 55,800 | 55,800 |
| Goodwill | 14,608 | 14,608 |
| Restricted cash | 4,858 | 4,858 |
Item 1. Financial Statements.
FAQ
- What is Revolution Medicines, Inc.'s PP&E (net)?
- Revolution Medicines, Inc. (RVMD) reported PP&E (net) of $31.48M in Q1 2026.
- How has Revolution Medicines, Inc.'s PP&E (net) changed year-over-year?
- Revolution Medicines, Inc.'s PP&E (net) increased by 15.9% year-over-year, from $27.15M to $31.48M.
- What is the long-term trend for Revolution Medicines, Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), Revolution Medicines, Inc.'s PP&E (net) has grown at a 30.1% compound annual growth rate (CAGR), from $8.9M to $33.19M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Revolution Medicines, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude